Methyl all-cis-5,8,11,14,17-eicosapentaenoate (CAS 2734-47-6)

Methyl all-cis-5,8,11,14,17-eicosapentaenoate, an organic compound, has been a subject of scientific research in various fields, including chemistry, biochemistry, and nutrition. Researchers have investigated the mechanisms and applications of methyl all-cis-5,8,11,14,17-eicosapentaenoate, uncovering its unique properties and potential uses. This compound is an ester derivative of eicosapentaenoic acid (EPA), a long-chain polyunsaturated fatty acid found in marine sources. Methyl all-cis-5,8,11,14,17-eicosapentaenoate has been studied extensively for its biological activities, particularly its anti-inflammatory and immunomodulatory effects. The mechanisms underlying these effects involve the modulation of signaling pathways involved in inflammation and immune response, such as the inhibition of pro-inflammatory mediators and the regulation of immune cell functions. This has led to investigations into its potential applications in the prevention and management of chronic inflammatory conditions, as well as in the development of functional foods and dietary supplements. Moreover, methyl all-cis-5,8,11,14,17-eicosapentaenoate has been studied for its role in cellular membrane function and lipid metabolism. It serves as a precursor for the synthesis of bioactive lipid mediators, such as resolvins and protectins, which play important roles in resolving inflammation and maintaining tissue homeostasis. The research applications of methyl all-cis-5,8,11,14,17-eicosapentaenoate contribute to advancements in understanding the biological activities and health benefits associated with omega-3 fatty acids, providing insights into its potential applications in nutrition and human health.